NASDAQ · EXOZ
Healthcare · Biotechnology
$6.16
Down-$0.42 (-6.31%)
Updated Sep 17, 2026, 9:22 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 20 trading sessions · Daily adjusted prices
EXOZ closed at $6.16 after 20 trading sessions, down 3.75% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $6.38 | $6.485 | $6.00 | $6.16 | 12.29K |
| Sep 15, 2026 | $6.25 | $6.785 | $6.05 | $6.575 | 11.16K |
| Sep 14, 2026 | $6.25 | $6.34 | $6.25 | $6.28 | 5.63K |
| Sep 11, 2026 | $6.09 | $6.65 | $6.09 | $6.3015 | 4.56K |
| Sep 10, 2026 | $6.25 | $6.535 | $6.00 | $6.17 | 8.33K |
| Sep 9, 2026 | $6.61 | $6.92 | $6.17 | $6.17 | 8.42K |
| Sep 8, 2026 | $7.14 | $7.25 | $6.30 | $6.31 | 18.65K |
| Sep 4, 2026 | $7.10 | $7.10 | $6.85 | $6.85 | 1.31K |
| Sep 3, 2026 | $7.00 | $7.00 | $6.45 | $6.80 | 3.97K |
| Sep 2, 2026 | $6.5884 | $6.79 | $6.45 | $6.79 | 925.75 |
| Sep 1, 2026 | $7.22 | $7.22 | $6.50 | $6.50 | 4.13K |
| Aug 31, 2026 | $7.28 | $7.28 | $6.73 | $6.73 | 841.75 |
| Aug 28, 2026 | $7.01 | $7.38 | $6.71 | $7.1677 | 2.78K |
| Aug 27, 2026 | $6.64 | $7.175 | $6.64 | $7.175 | 1.07K |
| Aug 26, 2026 | $6.9083 | $7.60 | $6.8513 | $7.525 | 1.49K |
| Aug 25, 2026 | $7.18 | $7.80 | $6.4501 | $7.53 | 3.22K |
| Aug 24, 2026 | $6.62 | $6.95 | $6.62 | $6.95 | 1.53K |
| Aug 21, 2026 | $8.01 | $8.01 | $7.08 | $7.15 | 10.23K |
| Aug 20, 2026 | $6.50 | $7.71 | $6.42 | $7.04 | 13.69K |
| Aug 19, 2026 | $6.08 | $6.45 | $6.08 | $6.40 | 3.12K |
The latest Smart Investors Daily articles mentioning EXOZ.
EXOZ research
Company profile and research snapshot.
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Sep 8, 2026
* Program expected to commence in Q4 2026 and establish a roadmap for larger-scale production in 2027LOS ANGELES, CA / ACCESS Newswire / September 8, 2026 / Today, Inc. (NASDAQ:EXOZ) ("") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced that it has entered into an agreement with Curia Global, Inc.
Benzinga · Aug 20, 2026
Gainers Werewolf Therapeutics (NASDAQ:HOWL) stock moved upwards by 77.1% to $0.76 during Thursday's after-market session. The company's market cap stands at $19.8 million. Profusa (NASDAQ:PFSA) stock rose
Yahoo · Aug 11, 2026
Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-enhanced enzymes that transform abundant feedstock into valuable nutraceuticals and novel medicines - announced the plan to host a webinar on Thursday, August 20, 2026, at 5:00 PM Eastern ...
Benzinga · Jul 23, 2026
Company to collaborate with Lawrence Berkeley National Laboratory on AI-enabled digital twins designed to accelerate optimization of enzyme-driven manufacturing processes.The 9-month project awarded approximately
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning EXOZ.
